Floatz logo

Allogeneic Cluster Of Differentiation 8 + Memory T-Cells

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Robert LowskyCell therapyPhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
65/ 100

Competitive context

212 Active assets in the Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Weill Medical College of Cornell University
Phase 2BBB
CHLORAMBUCIL
Ascentage Pharma Group Inc.
Phase 4BBB
Apg-2575
Henan Cancer Hospital
Phase 3BBB
Irinotecan
IGM Biosciences, Inc.
Phase 2BBB
PREDNISONE TABLETS
AstraZeneca
Phase 3BBB

View all 50 →

Same molecule, other indications

Allogeneic Cluster Of Differentiation 8 + Memory T-Cells is also rated in:

Chronic Myeloid LeukemiaDormant
B
Indicative ·
57 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
57 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →